Clinical Trial Update: Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating seizure prevention in traumatic brain injury using levetiracetam and lacosamide; currently RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Keppra (levetiracetam)
• Vimpat (lacosamide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Traumatic Brain Injury | Phase 4 | Status: RECRUITING